Federal Circuit Appeals by Industry
July 24, 2019
Pharma / biotech cases are among the most often appealed from district courts to the Federal Circuit, with consumer products and e-commerce and software trailing closely behind.
RPX is tracking Federal Circuit-related trends to provide companies with a holistic view of the litigation landscape that can help inform their strategies when it comes to managing patent risk.
Why RPX
At RPX, we believe that the best defense is a good offense. That’s why since our inception in 2008, we’ve purchased rights to over 47,500 patent assets to mitigate patent risk for our members. As one of the most active participants in the patent market, RPX has compiled proprietary data on thousands of litigations and patent transactions. With RPX, companies have access to reliable information about the patent market, helping them to better understand this constantly changing landscape. Our tracking of Federal Circuit-related trends provides companies with a more complete view of the litigation landscape.
As the patent litigation landscape continues to change, RPX will keep innovating and staying ahead of the future risks our members face. Contact us today to find out how RPX can help your company manage patent risk at every level.